but avxl stock took a 40% dive...they were expecting 'average' results, but the results are come out actually really good with the congnition improvement at wk5 for all 32 patients. P
Longs are giving scientific reasons for stock to go up tomorrow, based on the positive data presented. Shorts have NOT ONCE mentioned anything about the data....they just say its going to go down. Why ??
we don't know what was actually said by the 4 people that presented it. Tomorrow in the PR there will be much more information - business updates, next timelines for 2/3, more details on the 2a and ongoing part 2.
Too many people here guessing...Dr. M will clear things up. He did not do a R/S for no reason..he knows the science is the best there is today.
Shorts are cherry picking that it is not perfect results...yes it is not perfect. But what we have today is WAY from perfect, and what are in trials - AXON - does not come close to AVXL scores...that are compared to baseline (WHICH IS SOC - DPZ)..much better comparison than placebo.
AXVL is top of the game in the field of ALZ treatment and REVERSAL...nothing in the market or trials have this result. So what valuation should we give AVXL ? The market is $20 billion.
bashers are working overtime here, so there might be a small dip in the morning...stock goes to mid 7s, but from that point on its UPTIME...it will bounce back strong and end day mid 9s. This will show instutional buying. Shorts will be covering 1st thing in the AM.
NOTHING in the preso has shown anything negative...fantastic stats vs. SOC (DPZ) at week 5. AXON even cannot beat these results at JUST week 5.
CEO will also come up with PR which will be very positive, as it will be in biz language, not scientific like the 15 min preso. May talk forward looking statemnts - when will phse 2/3 start, partnerships etc.
all indications are up, better than SOC, going into ph 2/3, priced 1/5 that of AXON with way better numbers at week 5.
what is the result of all the 32 patients at 35 days compared to DPZ...same with results of the 11 at 6 weeks. CEO will give it clearly on Monday. The preso did not clearly show this.
too many people that don't understand the science are trying to intrepet it incorrectly. All scientific folks are saying results are really strong..way better than AXON.
yes but the stock never reached $50/100....its at $8, after taking a 40% haircut last 3 days. And the results actually met the expectations if you talk to a scientist. If you talk to a basher it didn't.
They showed fantastic results, consistent with July results. Company going into ph 2/3, same as AXON going into ph 3...but results so far are far superior than AXON at 1/5 market cap.
I hope the release on Monday will have more details.
every oral presentation is only 15 mins...on every day. They would not have gotten more time on Friday.
It will all be in the release out Monday...more details.
Cogstate is one of the presenters tomorrow at the conference....to show how the subjects have improved in their cognitive skills.
Cogstate - cognitive tasks provide rapid, sensitive and valid measurement of distinct cognitive functions.
 profit taking ahead of the results. That is normal given the run up.
 Surge of bashers on twitter - Adam F, Martin....clueless bashers feeding on the profit selling.
 Misintrepetation of the abstract....it was generic for July too. But abstract clearly says it is going to be good news.
Nothing here implies science failed..that the distinguished scientific board is nonsense,..that all recent research on sigma-1 on ALZ is not true.
Market cap should at least be 1/2 of AXON on Monday ----800M.
the herd following the blind....
this was back in 2010. So Martin Shkreli knows more than the analysis this publication did ? He is a hedge fund guy !!
thanks !! I was checking on that too..so they are consistent with their abstracts.
for your answer, look at AXON...market cap 1.6 billion, results down the road slightly better than SOC today.
AVXL at only 300 M is a better bet..with superior treatment.